- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Freenome Inc (FRNM)
Freenome Inc stock price live, this page displays NASDAQ FRNM stock exchange data. View the FRNM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Freenome Inc real time stock price chart below.
What Is the Freenome Inc Stock Price Today?
The Freenome Inc stock price today is 11,56.
What Is the Stock Symbol for Freenome Inc?
The stock symbol for Freenome Inc is "FRNM."
What Stock Exchange Does Freenome Inc Trade On?
Freenome Inc is listed and trades on the NASDAQ stock exchange.
Is Freenome Inc a Good Stock to Buy?
Determining whether Freenome Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the FRNM quote. (ISIN: US35661P1003)
What Is the Freenome Inc Stock Price Today?
The Freenome Inc stock price today is 11,56.
What Is the Stock Symbol for Freenome Inc?
The stock symbol for Freenome Inc is "FRNM."
What Stock Exchange Does Freenome Inc Trade On?
Freenome Inc is listed and trades on the NASDAQ stock exchange.
Is Freenome Inc a Good Stock to Buy?
Determining whether Freenome Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the FRNM quote. (ISIN: US35661P1003)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.93
11.67
52 wk Range
9.71
17.50
FRNM is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.9311.67
52 wk Range
9.7117.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
FRNM Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
18.00
Upside
+55.71%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Form 4 Freenome Inc For: 20 October- Investing.com
Freenome stock hits 52-week low at 9.94 USD- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 18.00
(+55.71% Upside)
Freenome Inc Earnings Call Summary for Q3/2026
- Q3 revenue surged to $183.5M from $1M year-over-year, driven by $180M FDA approval milestone payment for SimpleScreen CRC test.
- Company swung to profit with $0.58 diluted EPS vs. $0.95 loss prior year; ended quarter with $430M cash, funding operations into 2028.
- Abbott launched SimpleScreen CRC Sept. 30; over 2,000 clinical sites requested kits in first 30 days with 800-person sales force deployed.
- Q4 2026 revenue guided at $2M-$4M; full-year forecast $192M-$194M. Expects $70M milestone payment upon CRC v2 approval in H2 2027.
- Pipeline catalysts include December single-cancer readouts, Q2 2027 multi-cancer data, and CRC version 2 supplemental PMA filing by year-end.
Last Updated: 2026/11/11, 00:34
Read Full TranscriptEarnings
Latest Release
Nov 11, 2026
EPS / Forecast
0,58 / --
Revenue / Forecast
183,5M / --
Compare FRNM to Peers and Sector
Metrics to compare | FRNM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipFRNMPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.3x | −23.2x | −0.2x | |
PEG Ratio | - | −2.35 | 0.00 | |
Price/Book | −0.9x | 3.0x | 2.6x | |
Price / LTM Sales | 35.1x | 16.3x | 2.8x | |
Upside (Analyst Target) | 55.7% | 8.8% | 60.5% | |
Fair Value Upside | Unlock | −15.7% | 7.8% | Unlock |
Freenome, Inc., a biotechnology company, develops blood-based screening tests to detect cancer in the United States. The company offers an early cancer detection platform that integrates multiomics, artificial intelligence, and machine learning to uncover complex biological signals associated with cancer. It develops SimpleScreen™ CRC, a blood-based test, including a test for colorectal cancer screening, as well as tests for multi-cancer and multi-disease detection, such as lung, breast, cervical, liver, pancreatic, and esophageal cancers. The company was founded in 2014 and is headquartered in Brisbane, California.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Freenome (FRNM) Stock Price Today?
The Freenome stock price today is 11,56 USD.
What Stock Exchange Does Freenome Trade On?
Freenome is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Freenome?
The stock symbol for Freenome is "FRNM."
What Is the Freenome Market Cap?
As of today, Freenome market cap is 1,24B USD.
What Is Freenome's Earnings Per Share (TTM)?
The Freenome EPS (TTM) is -8,84.
From a Technical Analysis Perspective, Is FRNM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Freenome Stock Split?
Freenome has split 0 times.
How Many Employees Does Freenome Have?
Freenome has 378 employees.
What is the current trading status of Freenome (FRNM)?
As of Nov 12, 2026, Freenome (FRNM) is trading at a price of 11,56 USD, with a previous close of 11,56 USD. The stock has fluctuated within a day range of 10,93 USD to 11,67 USD, while its 52-week range spans from 9,71 USD to 17,50 USD.
What Is Freenome (FRNM) Price Target According to Analysts?
The average 12-month price target for Freenome is 18,00 USD, with a high estimate of 21 USD and a low estimate of 17 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +55,71% Upside potential.
What Is the FRNM After Hours Price?
FRNM's last after hours stock price is 11,50 USD, the stock has decreased by -0,06, or -0,52%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.